Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Rachel Lai
Institution:
Memorial Sloan Kettering Cancer Center
Observed institution:
Memorial Sloan Kettering Cancer Center
ORCID:
0009-0000-2330-9914
Observed ORCIDs:
0009-0000-2330-9914,
0000-0003-2015-4835
OpenAlex ID:
A5123218266
RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026
·
Alexander J. Pfeil
, Tom Zhang
, et al.
·
Clinical Cancer Research
·
3
PDF
Data from Patient-Reported Outcomes in FLAURA2: Osimertinib with or without Chemotherapy in Patients with Previously Untreated EGFR-Mutated Advanced Non–Small Cell Lung Cancer
2026
·
Jhanelle E. Gray
, Konstantin Laktionov
, et al.
Supplementary Data from Patient-Reported Outcomes in FLAURA2: Osimertinib with or without Chemotherapy in Patients with Previously Untreated EGFR-Mutated Advanced Non–Small Cell Lung Cancer
2026
·
Jhanelle E. Gray
, Konstantin Laktionov
, et al.
Supplementary Data2 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026
·
Alexander J. Pfeil
, Tom Zhang
, et al.
Supplementary Data3 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026
·
Alexander J. Pfeil
, Tom Zhang
, et al.
Data from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026
·
Alexander J. Pfeil
, Tom Zhang
, et al.
Supplementary Data6 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026
·
Alexander J. Pfeil
, Tom Zhang
, et al.
Supplementary Data1 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026
·
Alexander J. Pfeil
, Tom Zhang
, et al.
Supplementary Data5 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026
·
Alexander J. Pfeil
, Tom Zhang
, et al.
Supplementary Data4 from RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236
2026
·
Alexander J. Pfeil
, Tom Zhang
, et al.
Show more works
View as search
Works count:
10
Citation count:
3
H-index:
1
I10-index:
Year
Topic
Type